The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix)
- 1 January 1977
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 11 (6) , 419-421
- https://doi.org/10.1007/bf00562931
Abstract
After a two week washout period 25 patients with moderate to severe essential hypertension were treated with pindolol. In 12 patients the reduction in blood pressure was excellent and treatment with pindolol was continued. In 13 patients treatment was supplemented subsequently with clopamide and 12 patients had a satisfactory result. Side-effects were few and mild.Keywords
This publication has 16 references indexed in Scilit:
- Hemodynamic Effect of Pindolol in Essential Hypertension with Special Reference to the Resistance and Capacitance Vessels of the ForearmActa Medica Scandinavica, 1976
- β-Adrenergic Blockade in Diuretic-Treated Patients with Essential HypertensionNew England Journal of Medicine, 1975
- Combination therapy of essential hypertension with pindolol (Visken) and hydralazineEuropean Journal of Clinical Pharmacology, 1975
- Treatment of hypertension with a new beta-blocking agent, pindolol (Visken®)European Journal of Clinical Pharmacology, 1973
- Carbohydrate tolerance during beta-adrenergic blockade in hypertensionEuropean Journal of Clinical Pharmacology, 1973
- The effect of pindolol, a beta-receptor blocking agent, in heart rate and blood-pressure during submaximal and maximal exerciseEuropean Journal of Clinical Pharmacology, 1972
- The long-term treatment of hypertension with thiazide diureticsPublished by Oxford University Press (OUP) ,1971
- Propranolol in the treatment of hyperkinetic heart syndrome, idiopathic hypertrophic subaortic stenosis, and systemic hypertensionAmerican Heart Journal, 1970
- Carbohydrate metabolism during treatment with chlorthalidone and ethacrynic acid.BMJ, 1968
- Clinical evaluation of Brinaldix. A new oral diureticPublished by Oxford University Press (OUP) ,1965